A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain (clinicaltrials.gov) - Oct 2, 2026 - P=N/A | N=1300 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Trial completion date: May 2026 ➔ Nov 2026
Trial completion date • Hematological Malignancies • Myelodysplastic Syndrome • Oncology
|